Literature DB >> 7524838

Maternal serum screening.

J C Carroll1.   

Abstract

Maternal serum screening (MSS) measures three serum markers: alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol, from which the risk of fetal Down syndrome or open neural tube defect is calculated. Initially, 8% of women will have positive results. I present a protocol for investigating these women. Family physicians should be informed about MSS so they can give their patients information and guidance.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7524838      PMCID： PMC2380361     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


  20 in total

1.  Screening for high-risk pregnancies with maternal serum alpha-fetoprotein (MSAFP). The Canadian Society of Clinical Chemists' Task Force on MSAFP Screening.

Authors:  A R MacRae
Journal:  Clin Biochem       Date:  1990-12       Impact factor: 3.281

2.  Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.

Authors:  T A Doran; G H Valentine; P Y Wong; G Wielgosz; R J Benzie; H C Soltan; M R Jenner; P A Morland; R J Montgomery; L C Allen
Journal:  CMAJ       Date:  1987-08-15       Impact factor: 8.262

3.  Absence of need for amniocentesis in patients with elevated levels of maternal serum alpha-fetoprotein and normal ultrasonographic examinations.

Authors:  A S Nadel; J K Green; L B Holmes; F D Frigoletto; B R Benacerraf
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

4.  Second-trimester maternal serum alpha-fetoprotein levels and the risk of subsequent fetal death.

Authors:  D K Waller; L S Lustig; G C Cunningham; M S Golbus; E B Hook
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

5.  Temporal trends in the prevalence of congenital malformations at birth based on the birth defects monitoring program, United States, 1979-1987.

Authors:  L D Edmonds; L M James
Journal:  MMWR CDC Surveill Summ       Date:  1990-12

6.  Lisinopril and enalapril in hypertension: a comparative study using ambulatory monitoring.

Authors:  J Conway; A J Coats; R Bird
Journal:  J Hum Hypertens       Date:  1990-06       Impact factor: 3.012

7.  Assessment of the antihypertensive effect of lisinopril using 24-hour ambulatory monitoring.

Authors:  D Herpin; D Conte
Journal:  J Hum Hypertens       Date:  1989-06       Impact factor: 3.012

8.  Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.

Authors:  M S DiMaio; A Baumgarten; R M Greenstein; H M Saal; M J Mahoney
Journal:  N Engl J Med       Date:  1987-08-06       Impact factor: 91.245

9.  Cesarean section before the onset of labor and subsequent motor function in infants with meningomyelocele diagnosed antenatally.

Authors:  D A Luthy; T Wardinsky; D B Shurtleff; K A Hollenbach; D E Hickok; D A Nyberg; T J Benedetti
Journal:  N Engl J Med       Date:  1991-03-07       Impact factor: 91.245

Review 10.  Ultrasonographic screening for the Down syndrome fetus.

Authors:  C J Lockwood; L Lynch; R L Berkowitz
Journal:  Am J Obstet Gynecol       Date:  1991-08       Impact factor: 8.661
View more
  3 in total

1.  Assessment of the Effectiveness of Genetic Counseling by Telephone Compared to a Clinic Visit.

Authors:  Karan K Sangha; Anita Dircks; Sylvie Langlois
Journal:  J Genet Couns       Date:  2003-04       Impact factor: 2.537

2.  Ethics of maternal serum screening.

Authors:  R A Blattel
Journal:  Can Fam Physician       Date:  1994-12       Impact factor: 3.275

3.  Family physicians in maternity care. Still in the game? Report from the CFPC's Janus Project.

Authors:  A J Reid; I Grava-Gubins; J C Carroll
Journal:  Can Fam Physician       Date:  2000-03       Impact factor: 3.275
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.